These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16778129)

  • 1. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
    Chung AW; Hsiang YN; Matzke LA; McManus BM; van Breemen C; Okon EB
    Circ Res; 2006 Jul; 99(2):140-8. PubMed ID: 16778129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
    Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
    Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
    Wang JH; Kwon HJ; Jang YJ
    Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor.
    Zhu M; Bi X; Jia Q; Shangguan S
    Biomed Pharmacother; 2010 Mar; 64(3):208-13. PubMed ID: 19932587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive feedback regulation between MMP-9 and VEGF in human RPE cells.
    Hollborn M; Stathopoulos C; Steffen A; Wiedemann P; Kohen L; Bringmann A
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4360-7. PubMed ID: 17724228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease.
    Zygalaki E; Kaklamanis L; Nikolaou NI; Kyrzopoulos S; Houri M; Kyriakides Z; Lianidou ES; Kremastinos DT
    Clin Biochem; 2008 Jan; 41(1-2):82-7. PubMed ID: 17961532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and downregulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature.
    Chung AW; Luo H; Tejerina T; van Breemen C; Okon EB
    Atherosclerosis; 2007 Nov; 195(1):e1-8. PubMed ID: 17316652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin.
    Weihrauch D; Lohr NL; Mraovic B; Ludwig LM; Chilian WM; Pagel PS; Warltier DC; Kersten JR
    Circulation; 2004 May; 109(19):2343-8. PubMed ID: 15136506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.
    Chung AW; Yang HH; Kim JM; Sigrist MK; Chum E; Gourlay WA; Levin A
    Circulation; 2009 Sep; 120(9):792-801. PubMed ID: 19687355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
    Sasso FC; Torella D; Carbonara O; Ellison GM; Torella M; Scardone M; Marra C; Nasti R; Marfella R; Cozzolino D; Indolfi C; Cotrufo M; Torella R; Salvatore T
    J Am Coll Cardiol; 2005 Sep; 46(5):827-34. PubMed ID: 16139132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of angiostatin on vascular leakage and VEGF expression in rat retina.
    Sima J; Zhang SX; Shao C; Fant J; Ma JX
    FEBS Lett; 2004 Apr; 564(1-2):19-23. PubMed ID: 15094037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.
    Janssen A; Hoellenriegel J; Fogarasi M; Schrewe H; Seeliger M; Tamm E; Ohlmann A; May CA; Weber BH; Stöhr H
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2812-22. PubMed ID: 18408187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging is associated with increased matrix metalloproteinase-2 activity in the human aorta.
    McNulty M; Spiers P; McGovern E; Feely J
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):504-9. PubMed ID: 15831360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
    Yang EV; Sood AK; Chen M; Li Y; Eubank TD; Marsh CB; Jewell S; Flavahan NA; Morrison C; Yeh PE; Lemeshow S; Glaser R
    Cancer Res; 2006 Nov; 66(21):10357-64. PubMed ID: 17079456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.